COVERAGE
Biotech, IA & Venture Capital | Time for Big Mergers?
May 7, 2025
Read time: 2 min
“At a time when biotechs are struggling to raise funds, the convergence with Artificial Intelligence technologies is attracting new investors who are more tech-savvy and less life science-oriented.”
Partner Anthony Paronneau explains the changes taking place and the challenges facing entrepreneurs at this crossroads in an interview with Jacques-Bernard Taste.
Read the full article in French (via paywall).
You may also like
